AcquisitionOther
Innoviva, Inc. acquired Entasis Therapeutics Holdings Inc
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Innoviva, Inc. -> Entasis Therapeutics Holdings Inc · $2.20
Entasis brings to Innoviva an exciting portfolio that includes potentially first- and best-in-class medicines for the treatment of multidrug-resistant Gram-negative bacteria, including lead asset SUL-DUR.
Open source record (SEC) ↗